Users Discontinuing Anti-Obesity Medications Put On Weight Four Times Faster Than People Using Diet and Exercise

A recent study indicates that patients who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain lost weight much more quickly than those who stop conventional diet and exercise regimens.

Findings released in a major medical journal shows that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.

"People buying such treatments must be aware of the danger of rapid weight regain when the treatment ends," stated expert Dr. Susan Jebb.

That rate of regain means a reversion to starting mass within about one and a half years.

Analyzing Treatments

The research, which reviewed dozens of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.

Researchers point out that people who shed pounds through dieting typically see a more gradual weight regain—around 100 grams monthly—after stopping.

Understanding the Quick Rebound

Doctors propose the way of the jabs explains the accelerated weight return.

These medications copy a body's own chemical called GLP-1, which moderates hunger.

"Artificially providing GLP-1 levels far above than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' results in hunger is uncontrolled, making excessive eating a significant risk."

A Chronic Disease?

Medical guidelines advise the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

A number of clinicians say that, due to the high risk of relapse, the therapy might need to be long-term.

This view is echoed by pharmaceutical companies, who note that the results "highlight the long-term character of excess weight," comparing it to managing diseases like hypertension.

User Testimonies

People who have stopped the medication describe a powerful resurgence of hunger.

"It was like a trigger that goes on and you're instantly extremely hungry," said one woman.

The struggle is worsened if users have not developed lasting lifestyle or habit changes during therapy.

Significant Adoption

Recent estimates show that millions of people in the UK have used weight-loss jabs in the past year, with desire remaining high.

• Use is higher among women compared to males.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion obtain the medications through private healthcare rather than the NHS.

Finally, clinicians emphasize that while the jabs are powerful agents for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on integrated lifestyle changes.